Observational study of a motion capture device (AKIRA) in patients with ALS
Not Applicable
- Conditions
- Amyotrophic Lateral Sclerosis
- Registration Number
- JPRN-jRCT1030230648
- Lead Sponsor
- Hirai Manabu
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Recruiting
- Sex
- All
- Target Recruitment
- 35
Inclusion Criteria
1. Patients will be diagnosed with Definite ALS, Probable ALS, or Probable laboratory-supported ALS according to the El Escorial revised criteria for the diagnosis of ALS
2. Patients will be >= 20 years of age at the time the ICF is signed
3. Patients who can walk independently at a specified distance for video shooting
4. Patients who regularly visit the Yoshino Clinic about once a month
5. Patients who provided a signed and dated informed consent form (ICF) to participate in the study
Exclusion Criteria
1. Patients who have the presence of any clinically significant disease
2. Patients who are not eligible to participate in the study, as judged by the Investigator
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method - Motion data using AKIRA
- Secondary Outcome Measures
Name Time Method - ALSFRS-R score<br>- % Forced vital capacity (%FVC)<br>- expiratory gas analysis<br>- Laboratory Tests (creatine kinase, creatinine, uric acid)<br>- InBody (body composition)